RESUMO
Rotavirus is a leading cause of severe infectious diarrhea in infants and young children aged <5 years. Rotavirus infections have minimal to strong seasonality depending on geographical locations. In this study, a comprehensive retrospective analysis was performed to evaluate the association between rotavirus admission and multiple key meteorological variables, including air temperature, relative humidity, atmospheric pressure, and solar radiation over a 15-year period from 1995 to 2009 in Hong Kong. Rotavirus infections were found to show a distinct cyclical pattern with an annual peak in cold season. The weekly number of cases showed the strongest correlation with average air temperature of the previous 7 days (rho=-0.69; P<0.0001), followed by atmospheric pressure (rho=+0.67; P<0.0001); whereas only weak correlation with relative humidity (rho=-0.252; P<0.0001) and solar radiation (rho=-0.312; P<0.0001) was observed. Curve fitting regression analysis suggested that the correlation was nonlinear in nature in which the effect was more profound towards lower air temperature and higher atmospheric pressure conditions. In binary logistic regression analysis, a final model that included air temperature (≤ 20°C) and atmospheric pressure (≥ 1,013 hPa) predicted correctly 85.3% and 82.6% of weeks with rotavirus activity above and below the baseline level, respectively. In multivariate Poisson model, air temperature and solar radiation were independent factors associated with the weekly number of rotavirus cases, adjusted for seasonal variation. In summary, the current study provides evidence suggesting that local seasonal activity of rotavirus correlated strongly with air temperature, followed by atmospheric pressure but only minimally with relative humidity in pre-vaccine era.
Assuntos
Infecções por Rotavirus/epidemiologia , Tempo (Meteorologia) , Pressão Atmosférica , Pré-Escolar , Diarreia/epidemiologia , Feminino , Hong Kong/epidemiologia , Humanos , Umidade , Lactente , Masculino , Modelos Estatísticos , Estudos Retrospectivos , Estações do Ano , Luz Solar , TemperaturaRESUMO
Influenza seasons appear consistently in the temperate regions, but are more variable in tropical/subtropical regions. The determinant for such variation remains poorly understood. This study documented the activity of influenza over a 10-year period in Hong Kong; examining its association with changes in temperature and relative humidity. The two types of influenza exhibited different correlations with meteorological variations. Influenza A showed two seasonal peaks occurring respectively in winter/spring and summer months in most years. Influenza B showed a clear winter/spring peak, but its activity during summer months was more variable. Cold and humid conditions were associated with a higher activity of both influenza A and B. In contrast, hot and humid conditions were associated with a higher activity of influenza A, but were associated with only a moderate, less consistent increase in the activity of influenza B. A trend of increase in the magnitude of summer peaks of influenza A, but not influenza B, was observed. A hypothetical 2 degrees C rise in temperature would decrease the proportion of favorable days for influenza A in December-April from 78% to 57%, but an increase from 58% to 71% in May-November; with a similar effect (from 83% to 62%) for influenza B during December-April, but a modest change (from 17% to 18%) during May-November. The presence of two seasonal peaks of influenza annually emphasizes the need to evaluate the duration of protective immunity offered by vaccination. Further study on the effects of climate change and global warming on the activity of influenza is warranted.
Assuntos
Vírus da Influenza A/isolamento & purificação , Vírus da Influenza B/isolamento & purificação , Influenza Humana/epidemiologia , Influenza Humana/virologia , Estações do Ano , Clima , Hong Kong/epidemiologia , Humanos , Umidade , TemperaturaRESUMO
Measurements of transport of triglycerides (TG) in very low density lipoproteins (VLDL) were carried out in 59 patients by injection of radioactive glycerol, determinations of specific activities of VLDL-TG for 48 h thereafter, and treatment of the data by multicompartmental analysis. The patients were divided into three groups: normal weight (89-120% ideal weight), mildly obese (120-135% ideal weight), and markedly obese (135% ideal weight). They had varying levels of VLDL-TG ranging from normal to markedly elevated. In many subjects, there was a positive correlation between concentrations and transport of VLDL indicating that overproduction of VLDL-TG contributed to hypertriglyceridemia. In others, and particularly in several markedly obese subjects, transport rates were greatly increased without significant hypertriglyceridemia, suggesting that they had enhanced capacity to clear TG. In all groups, however, there were patients whose degree of hypertriglyceridemia seemed out of proportion to their transport rates. This finding and the fact that many patients have increased secretion of VLDL-TG without elevated plasma TG suggests that both overproduction of VLDL-TG and insufficient enhancement of clearance contributed to the development of hypertriglyceridemia.The data showed a poor correlation between transport rates determined by our multicompartment analysis and single-exponential analysis used previously by other investigators (r = 0.46); this comparison was not improved by segregating patients according to their degree of obesity. Although two conversion pathways (fast and slow synthetic paths) were required to fit the data, there was no correlation between transport rates and the ratio of the two pathways. Also, despite the known pathway of conversion of VLDL to low density lipoprotein, no correlation was found between VLDL-TG transport rates and estimated low density lipoprotein-cholesterol concentrations.
Assuntos
Hiperlipidemias/sangue , Lipoproteínas VLDL/sangue , Obesidade/sangue , Triglicerídeos/sangue , Transporte Biológico , Glicerol/sangue , Humanos , CinéticaRESUMO
A new kindred with asymptomatic hypobetalipoproteinemia is reported. The proband, age 67, differs from previously described cases in several respects: (a) unusually low levels of low density lipoprotein (LDL) cholesterol (4-8 mg/dl); (b) normal triglyceride levels; (c) low levels of high density lipoprotein; (d) mild fat malabsorption; and (e) a defect in chylomicron clearance. On a high-carbohydrate diet his plasma triglyceride levels, instead of rising, actually fell. Turnover of triglycerides in very low density lipoproteins (VLDL) was low (2.8 mg/kg per h). Fractional catabolic rate of LDL protein was just above the normal range (0.655/d) but net turnover was <10% of normal (0.65 mg/kg per d). The half-life of his chylomicrons was 29 min, five times the normal value. Postheparin lipoprotein lipase activity was normal and apolipoprotein C-II, the activator protein for lipoprotein lipase, was present and functional. Apolipoprotein C-III(1), however, was not detected in the VLDL fraction, a finding previously reported in patients with abetalipoproteinemia. Fecal excretion of cholesterol was almost twice normal; total sterol balance was increased by congruent with40%. The unusual features in the proband that distinguish him from previously described cases and from his affected first-degree relatives suggested that, in addition to the basic gene defect affecting LDL metabolism, he might have a second abnormality affecting clearance of chylomicrons and VLDL. The ratio of apolipoprotein E(3) to E(2) in his VLDL fraction was 0.93, just below the lower limit of normal, suggesting heterozygosity for E(3) deficiency. Whether or not this contributes to his hypertriglyceridemia remains to be established.
Assuntos
Quilomícrons/sangue , Hipobetalipoproteinemias/metabolismo , Hipolipoproteinemias/metabolismo , Lipoproteínas HDL/sangue , Adulto , Idoso , Apolipoproteínas/sangue , Proteínas Sanguíneas/análise , Colesterol/metabolismo , Gorduras na Dieta , Jejum , Feminino , Humanos , Hipobetalipoproteinemias/complicações , Hipobetalipoproteinemias/genética , Hipolipoproteinemias/complicações , Lipídeos/sangue , Lipoproteínas LDL/sangue , Lipoproteínas VLDL/sangue , Masculino , Pessoa de Meia-IdadeRESUMO
The ultrasonic absorption of myoglobin has been measured by the resonance and pulse-echo techniques as a function of pH. The absorption at a given frequency can be separated into pH-dependent and pH-independent contributions. Like other proteins, two peaks at pH 3 and 11.5 are observed which can be accounted for a proton-transfer reactions of the side-groups. In addition, the absorption undergoes a large increase within a small range of 0.2 pH unit at pH around 4, when denaturation of myoglobin occurs, indicating that the absorption is sensitive to the overall protein conformation. To elucidate the origin of the pH-independent component, the absorptions of several other globular proteins at neutral pH are also measured. The absorptions of these proteins exhibit a linear correlation with their isothermal compressibilities, suggesting that the pH-independent component is related to volume fluctuations of protein molecules. The activation energy of 4 kcal/mol found for this relaxation is consistent with such an interpretation.
Assuntos
Mioglobina , Análise Espectral , Ultrassom , Quimotripsinogênio , Concentração de Íons de Hidrogênio , Lactoglobulinas , Ribonuclease Pancreático , Soroalbumina Bovina , TemperaturaRESUMO
We have evaluated the efficacy of plant sterol preparations from two different sources and in two different physical forms in lowering the plasma cholesterol of a total of 46 patients with type II hyperlipoproteinemia when given in addition to appropriate diet therapy. In addition, the mechanisms of the hypocholesterolemic effect were investigated in 7 patients by a sterol balance technique. The maximal mean cholesterol lowering in response to any preparation was 12 percent, although it was much greater in some individual patients. Sterol balance data showed that plant sterols inhibit cholesterol absorption with maximal negative cholesterol balance in adults at a dose of 3 g/day of a tall oil sterol suspension. Interestingly, maximal plasma cholesterol reduction in the adult outpatients on this preparation was seen at the same dose level. Since the tall oil sterol suspension is relatively palatable and is poorly absorbed, it has potential value as an adjunct to dietary therapy in patients with mild hypercholesterolemia for whom long-term drug therapy is deemed advisable.
Assuntos
Hipercolesterolemia/tratamento farmacológico , Hiperlipidemias/tratamento farmacológico , Hiperlipidemias/genética , Fitosteróis/uso terapêutico , Colesterol/metabolismo , Humanos , Hipercolesterolemia/sangue , Hiperlipidemias/sangue , Fitosteróis/administração & dosagem , Fitosteróis/sangue , Triglicerídeos/sangueRESUMO
A method has been developed for measurement of fractional clearance rates of chylomicrons in man. The technique employs constant infusion of emulsified fat into the duodenum at a rate of 200 mg/kh/hr. After 5 hr of infusion, concentrations of triglycerides (TG) in the chylomicron fraction become constant for the subsequent 5 hr. Since the input of chylomicron-TG is known, fractional removal rates can be calculated from steady-state plasma levels. In 21 patients with normal TG levels, clearance rates for chylomicrons were extremely rapid (t1/2 for chylomicron-TG equals 4.5 +/- 2.9 (SD) min). In 30 patients with endogenous hypertriglyceridemia, clearance was generally prolonged (t1/2 equals 23 +/- 5.5 min). This delay in chylomicron clearance could have been due either to a defect in removal of all TG-rich lipoproteinarticles; a generalized defect in clearance capacity for plasma TG was apparently ruled out for most patients by the further observation that reduction of endogenous TG by caloric restriction caused chylomicron removal to return to normal. These studies also showed that endogenous-TG is removed much less efficiently than chylomicron-TG, and in some patients, this discrepancy is particularly marked.
Assuntos
Quilomícrons/metabolismo , Gorduras na Dieta/metabolismo , Hiperlipidemias/metabolismo , Triglicerídeos/sangue , Adulto , Colesterol/sangue , Clofibrato/farmacologia , Jejum , Humanos , Lipídeos/sangue , Lipoproteínas VLDL/sangue , Masculino , Pessoa de Meia-IdadeRESUMO
Medical dissolution of gallstones is feasible and has worked in clinical practice. Cholelithiasis is both common and a cause of significant morbidity nationally. Thus, to readdress the question posed in the introduction, should there be a more aggressive detection of populations at risk to consider prophylactic or early treatment of gallstones, one has to consider the following. Is it cost effective to treat people with asymptomatic stones when one half of gallstones detected at autopsy have not caused trouble in life? Will the reduction of one health hazard create other hazards, such as colonic cancer? Is it improving the quality of the patient's life after successful treatment to have the person return every year for ultrasound or radiologic check-ups for recurrence of gallstones? We feel that despite the low morbidity and mortality of elective surgery, medical dissolution of gallstones is a viable alternative, but, as with most medical decisions, the pros and cons of any therapy for cholelithiasis will ultimately be a decision based on the physician, the patient, and the situation. On the basis of what has been discussed in this review, the approach to treatment should involve a rational understanding of all alternatives.
Assuntos
Colelitíase/tratamento farmacológico , Monoterpenos , Doenças dos Ductos Biliares/tratamento farmacológico , Ácido Quenodesoxicólico/efeitos adversos , Ácido Quenodesoxicólico/farmacologia , Colagogos e Coleréticos , Dieta , Combinação de Medicamentos/uso terapêutico , Humanos , Óleos Voláteis , Terpenos/uso terapêutico , Ácido Ursodesoxicólico/uso terapêuticoRESUMO
In 14 patients with reflux esophagitis previously treated with antacids, the effects of addition of cimetidine on biliary lipids were studied. Each subject served as his own control, but no placebo medication was used. It was found that cimetidine (300 mg p.o. q.i.d.), over a 6-mo period of therapy, did not significantly alter lipid composition of fasting gallbladder bile, biliary lipid secretions, bile acid pool size, and its internal composition. In addition to detailed biliary studies, other observations were also made. Symptomatically, most of the patients responded favorably to cimetidine, and 9 of the 14 patients reported virtual elimination of bothersome symptoms while taking this medication. Concomitant with symptomatic improvement, daily antacid requirement was significantly reduced. Lower esophageal sphincter pressure was unaffected by cimetidine. No significant side effects were noted in this series of patients.
Assuntos
Bile/metabolismo , Cimetidina/farmacologia , Esofagite Péptica/tratamento farmacológico , Guanidinas/farmacologia , Metabolismo dos Lipídeos , Idoso , Bile/efeitos dos fármacos , Ácidos e Sais Biliares/análise , Ácidos e Sais Biliares/metabolismo , Junção Esofagogástrica/fisiologia , Jejum , Humanos , Masculino , Pessoa de Meia-Idade , PressãoRESUMO
Studies were carried out to determine effects of combined chemotherapy in patients with hyperlipidemia. In one study, 14 patients were treated first with colestipol and then with the combination of colestipol and clofibrate. In a second study, six patients were given clofibrate followed by addition of phytosterols. The following measurements were made in most patients: (1) plasma lipid concentrations, (2) fecal excretions of neutral steroids and bile acids, and (3) lipid composition of gallbladder bile. In six patients of the first study, hepatic secretion rates of biliary lipids and pool sizes of bile acids were also estimated. In the first study, colestipol alone caused a marked increase in fecal bile acids that resulted in a sizable decrease in plasma cholesterol concentrations (average 21 percent). In several patients, however, triglycerides were increased somewhat by colestipol. Despite interruption of the enterohepatic circulation of bile acids, the bile acid pool was not reduced, since a compensatory increase took place in bile acid synthesis. Also, except in one patient who developed gallstones following institution of colestipol, saturation of gallbladder bile with cholesterol was not markedly increased by this drug alone. Addition of clofibrate frequently produced a further decrement in plasma cholesterol, and the mild hypertriglyceridemia induced by colestipol was reversed. However, colestipol plus clofibrate usually caused a striking increase in saturation of gallbladder bile. Previous studies have shown that clofibrate causes a flux of cholesterol from tissue pools by simultaneously decreasing cholesterol synthesis and increasing its excretion. To further increase cholesterol excretion, phytosterols, which block cholesterol absorption, were added to clofibrate in the second study. Although phytosterols did not cause a further reduction in plasma cholesterol in these particular patients, they nevertheless greatly enhanced cholesterol excretion.
Assuntos
Clofibrato/uso terapêutico , Colestipol/uso terapêutico , Hiperlipidemias/tratamento farmacológico , Fitosteróis/uso terapêutico , Poliaminas/uso terapêutico , Adulto , Bile/metabolismo , Ácidos e Sais Biliares/metabolismo , Colesterol/metabolismo , Quimioterapia Combinada , Fezes/análise , Humanos , Hipercolesterolemia/metabolismo , Metabolismo dos Lipídeos , Fígado/metabolismo , Masculino , Pessoa de Meia-Idade , Esteroides/metabolismo , Triglicerídeos/sangueRESUMO
In this study a technique is described for estimating net absorption of total cholesterol (endogenous + exogenous) that enters the intestine. The method employs intubation of patients with a 3-lumen tube that contains a 10-cm mixing segment in the duodenum and a 100-cm absorption segment in the jejunum. A liquid formula diet containing varying amounts of exogenous cholesterol is infused continuously into the upper duodenum for a period of several hours; the formula diet stimulates constant contraction of the gallbladder and thus provides for continous secretion of biliary cholesterol sitosterol as a marker, the input of endogenous + exogenous cholesterol can be measured at the end of the 10-cm mixing segment. Net cholesterol absorption is estimated from the disappearance of cholesterol relative to beta-sitosterol over the next 100-cm of jejunum. When radioactive cholesterol was also used as a marker, radioactivity usually disappeared more rapidly than the mass of choleesterol over the absorption segment; this suggests that a significant amount of isotope exchange occurs in the upper intestine. Using beta-sitosterol as a marker, the extent of exchange can be determined. In six patients, cholesterol inputs ranged from 51 to 118 mg/hr, and net percentage absorption was 34-56%. When inputs of cholesterol were acutely increased by enhancing exogenous cholesterol, absolute absorption was uniformly increased, but percentage absorption either remained the same or was decreased somewhat. Changine inputs of beta-sitosterol had a striking effect on cholesterol absorption, and relatively small increments of beta-sitosterol almost always produced corresponding reductions in uptake of cholesterol. The intestinal perfusion method appears to provide certain advantages over previous techniques for estimating total cholesterol entering the upper intestine, including that derived from both endogenous and exogenous sources. Measurements can be made over short periods of time, and the method allows for determination of effects of acute changes in the intestinal milieu on cholesterol absorption. Finally, the technique defines the extent of isotope exchange between cholesterol in the intestinal mucosa and in the lumen.
Assuntos
Colesterol na Dieta , Colesterol/metabolismo , Absorção Intestinal , Adulto , Ritmo Circadiano , Humanos , Métodos , Pessoa de Meia-Idade , PerfusãoRESUMO
One of the potential complications of bile acid therapy for gallstone disease is the promotion of intestinal absorption of cholesterol, thereby increasing the influx of cholesterol in body pools. To determine whether bile acid feeding is associated with an increased absorption of intestinal cholesterol, absorption measurements were made in 8 obese subjects given chenodeoxycholic acid (CCDA) or Bilron (750 mg/day). The bile acids were given in random order, separated by control periods, in patients undergoing weight reduction. Absorption of cholesterol (mass and percent) and of bile acids were determined by a technique of combined measurements of biliary lipid secretion and fecal steroid excretion. Our data showed that during treatment with either bile acid, a marked increase in pool size and hepatic secretion of bile acids occurred. However, despite an increased flux of bile acids through the intestinal tract, there was no significant increase in cholesterol absorption as compared to control periods. Absorption rates during administration of the two bile acids were approximately the same. Furthermore, plasma cholesterol concentrations were stable throughout both control and treatment periods. Bile acid absorption remained highly efficient (greater than 96%) during all periods, even with administration of exogenous bile acids.
Assuntos
Ácidos e Sais Biliares/metabolismo , Colesterol/metabolismo , Obesidade/terapia , Adulto , Idoso , Ácidos e Sais Biliares/uso terapêutico , Peso Corporal , Fezes/análise , Humanos , Absorção Intestinal , Metabolismo dos Lipídeos , Fígado/metabolismo , Masculino , Pessoa de Meia-Idade , Obesidade/metabolismoRESUMO
In patients with cholesterol gallstones, there is a diminished bile acid pool and the bile becomes supersaturated with cholesterol. Medical treatment has been aimed at re-expanding the pool to improve cholesterol solubility in bile but as yet the factors controlling the size of the bile acid pool' are unknown. Therefore the role of the liver and intestine in controlling bile acid pool size in the rat was studied and the effect of experimental expansion of the pool on bile acid metabolism and bile lipid composition examined. Bile acid absorption was increased from ileum made hyperplastic by previous jejunectomy and hepatic bile acid synthesis was increased by phenobarbitone treatment. Both jejunal resection and phenobarbitone significantly increased the size of the bile acid pool from 32.2 +/- SEM 0.94 mumoles/100 g body weight to 42.2 +/- 1.71 and 44.4 +/- 2.03 respectively. However, the effects of these experimental manipulations on bile acid secretion rate, enterohepatic cycling frequency, and synthesis rates were quite different. Jejunectomy caused a 56% increase in bile acid secretion and more rapid cycling of the bile acid pool but the enhanced absorption did not depress bile acid synthesis. In contrast, phenobarbitone markedly increased synthesis from 14.5 +/- 1.42 mumoles.100 g BW(-1). 24 hr(-1) to 25.9 +/- 3.19 but there was no significant change in bile acid secretion and the choleresis seen after phenobarbitone was mainly due to an increase in the bile acid-independent fraction of bile flow. In these experimental studies in the rat, expansion of the bile acid pool did not significantly change bile lipid composition or cholesterol solubility in bile.
Assuntos
Ácidos e Sais Biliares/metabolismo , Jejuno/fisiologia , Fenobarbital/farmacologia , Animais , Bile/análise , Ácidos e Sais Biliares/biossíntese , Colesterol/análise , Feminino , Íleo/metabolismo , Absorção Intestinal , Jejuno/cirurgia , Fígado/anatomia & histologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Tamanho do Órgão , Fosfolipídeos/análise , Ratos , Taxa Secretória , Estimulação QuímicaRESUMO
We investigated the natural history of cholelithiasis in 59 samples of stones from the gallbladder or common bile duct in 15 patients, using as a tracer for the timing of stone formation the 14C released into the environment during nuclear weapons testing. The ages of the stones were correlated with the dates of onset of symptoms and with other clinical data. None of 11 symptomatic patients had symptoms or complications until at least two years (mean +/- SD, 8.0 +/- 5.1 years) after stone formation began. There was a lag time of 11.7 +/- 4.6 years between initial stone formation and cholecystectomy. The growth rates of stones from 11 symptomatic patients and 4 asymptomatic patients were similar (2.6 +/- 1.4 and 2.6 +/- 1.1 mm per year). Studies of two stones retrieved from the common bile duct showed that one had the same age as a cholecystic stone; the other, removed two years after cholecystectomy, apparently grew in the common bile duct. The long latency period between the formation of gallstones and the onset of symptoms indicates that interruption of the natural progression of gallstone disease is potentially possible with medical therapy.
Assuntos
Radioisótopos de Carbono/análise , Colelitíase/metabolismo , Cinza Radioativa/análise , Feminino , Cálculos Biliares/metabolismo , Cálculos Biliares/cirurgia , Humanos , Masculino , Recidiva , Fatores de TempoRESUMO
Hepatic outputs of biliary lipids can be measured by intestinal perfusion techniques, either during constant infusion of liquid formula into the duodenum or through-out a 24-hour period during which time three meals are given along with an overnight fast. The purpose of this study was to compare these two methods for estimating secretion of biliary lipids. In 21 subjects, mean hourly outputs measured during continuous feeding were highly comparable to those during intermittent feeding, showing that the constant infusion technique gave valid estimations of overall daily secretion rates of biliary lipids. On the other hand, the intermittent mode of feeding showed phasic changes of outputs and composition of biliary lipids in response to feeding and fasting apart from total outputs over 24 hours. However, it takes longer to complete and requires the use of a meal marker. By combining the intestinal perfusion technique with measurements of fecal excretion of neutral steroids and bile acids, this method may be used to estimate absorption of cholesterol and bile acids from the intestine. Thus, these measurements allow quantification of a number of parameters of the enterohepatic circulation.
Assuntos
Ácidos e Sais Biliares/fisiologia , Colesterol/fisiologia , Comportamento Alimentar , Lipídeos/fisiologia , Fígado/metabolismo , Adulto , Idoso , Bile/metabolismo , Nutrição Enteral , Circulação Êntero-Hepática , Fezes/análise , Alimentos Formulados , Humanos , Hiperlipidemias/metabolismo , Absorção Intestinal , Metabolismo dos Lipídeos , Métodos , Pessoa de Meia-Idade , Obesidade/metabolismo , Fosfolipídeos/fisiologia , Taxa SecretóriaRESUMO
We have selected for this study a well-defined group of patients with moderately advanced but compensated alcoholic cirrhosis. They were well-nourished and had no ascites, varices, azotemia, or encephalopathy. Liver biopsy showed little or no necrosis and inflammation despite wide-spread fibrosis. Serum bilirubin, transaminase, alkaline phosphatase, albumin and globulins were essentially normal. Biochemical evidence for liver disease was restricted to modest elevation of BSP retention, gamma GTP, serum bile acid concentrations, and urinary bile acid excretion. Except for changes in the interrelationships among the three biliary lipids, they were generally spared the abnormalities of sterol metabolism described in other patients with more advanced, more active liver disease. Thus, striking abnormalities in the metabolism of cholesterol and bile acids probably require severe reductions in functioning hepatocellular mass, major portal-systemic shunting, high disease activity, or all three to become manifest.
Assuntos
Ácidos e Sais Biliares/metabolismo , Colesterol/metabolismo , Cirrose Hepática Alcoólica/metabolismo , Adulto , Bile/análise , Resina de Colestiramina/uso terapêutico , Dieta , Fezes/análise , Humanos , Absorção Intestinal , Lipídeos/sangue , Cirrose Hepática Alcoólica/tratamento farmacológico , Testes de Função Hepática , Masculino , Pessoa de Meia-Idade , Taxa Secretória , Esteroides/análiseRESUMO
We treated 70 patients with gallstones with chenodeoxycholic acid over 3 1/2 years and analyzed the factors influencing the outcome of therapy. This treatment was unsuccessful in 11 patients with radiopaque gallstones and in seven with nonfunctioning gallbladders, but 64 per cent with radiolucent gallstones treated for six months or more showed partial or complete gallstone dissolution, and of those whose bile became unsaturated with cholesterol, 100 per cent had evidence of dissolution. In patients with partial or complete gallstone dissolution, the mean post-treatment biliary cholesterol saturation index--0.78 +/- 0.04 (S.E.M.)--was significantly less (P less than 0.001), and the dose of chenodeoxycholic acid (14.4 +/- 1.0 mg per kilogram of body weight per day) significantly more (P less than 0.025) than in those whose gallstones did not change (1.15 +/- 0.04 and 10.6 +/- 1.2 respectively). In patients with radiolucent gallstones, the dose of chenodeoxycholic acid should be based on body weight; 14 to 15 mg per kilogram of body weight per day effectively lowers the saturation index and dissolves gallstones.
Assuntos
Ácido Quenodesoxicólico/uso terapêutico , Colelitíase/tratamento farmacológico , Adulto , Idoso , Bile/análise , Ácido Quenodesoxicólico/administração & dosagem , Ácido Quenodesoxicólico/efeitos adversos , Colelitíase/classificação , Colelitíase/metabolismo , Colesterol/análise , Colesterol/sangue , Avaliação de Medicamentos , Feminino , Seguimentos , Vesícula Biliar/fisiopatologia , Humanos , Fígado/efeitos dos fármacos , Fígado/patologia , Testes de Função Hepática , Masculino , Pessoa de Meia-Idade , Fatores de Tempo , Triglicerídeos/sangueRESUMO
The mechanisms for the hypolipidemic action of nicotinic acid were examined in 12 patients with hyperlipidemia. Most patients were studied in the hospital on a metabolic ward. The first month was a control period followed by 1 month on nicotinic acid. During treatment with nicotinic acid, the triglycerides (TG) decreased in total plasma by an average of 52% and in very low density lipoproteins (VLDL) by 36%. Transport rates of VLDL-TG were determined by multicompartmental analysis following injection of [3H]glycerol as a precursor. Nicotinic acid decreased transport (synthesis) of VLDL-TG by an average of 21%. Kinetic modeling of the VLDL-TG data suggested that the TG reduction was due to a decrease in TG content of VLDL and hence a reduction in lipoprotein size more than number. For the whole group, plasma cholesterol fell during nicotinic acid therapy by a mean of 22%. The drug produced no detectable changes in fecal excretions of cholesterol (neutral steroids) or bile acids. However, it induced a small but significant increment in hepatic secretion of biliary cholesterol that might have led to a net loss of cholesterol from the body even though this loss could not be detected by sterol balance. Despite this increase in outputs of biliary cholesterol, there was not a significant increase in molar % cholesterol or in % saturation of gallbladder bile. Therefore, it is doubtful that nicotinic acid enhances the risk for cholesterol gallstones.
Assuntos
Colesterol/sangue , Hiperlipidemias/tratamento farmacológico , Ácidos Nicotínicos/uso terapêutico , Triglicerídeos/sangue , Absorção , Adulto , Bile/análise , Colesterol/análise , Fezes/análise , Humanos , Lipídeos/análise , Lipoproteínas VLDL/sangue , Masculino , Pessoa de Meia-IdadeRESUMO
Because the action of rifampin induces hepatic microsomal enzymes, a study was carried out in four patients to determine whether this drug alters the composition of biliary lipids. Several different measurements were made while patients were both on and off rifampin therapy for various infective processes. These measurements included multiple determinations of lipid composition of gallbladder bile, the relative proportions f individual bile acids, and kinetics of cholic acid and chenodeoxycholic acid. In all four patients, the saturation of gallbladder bile increased during rifampin treatment, and the bile consistently became supersaturated. The relative portions of chenodeoxycholic acid and cholic acid were essentially unchanged by treatment, but total synthesis of bile acids increased in three tested patients with rifampin therapy. These results indicate that rifampin increases saturation of bile with cholesterol, but this increase is not due to a reduction in bile acid production.